N-(4-piperidinyl) (dihydroxybenzofuran or dihydro-2H-benzopyran)carboxamide derivatives
First Claim
1. A compound of the formula:
- ##STR126## an N-oxide form, a salt or a sterochemically isomeric form thereof, wherein;
A is a radical of the formula;
space="preserve" listing-type="equation">--CH.sub.2 --CH.sub.2 -- (a-1),
space="preserve" listing-type="equation">--CH.sub.2 --CH.sub.2 --CH.sub.2 -- (a-2), or
space="preserve" listing-type="equation">--CH.sub.2 --CH.sub.2 --CH.sub.2 --CH.sub.2 -- (a-3), wherein one or two hydrogem atoms in said radicals (a-1) to (a-3) may be replaced by a C1-6 alkyl radical;
R1 is hydrogen or halo;
R2 is hydrogen, amino, mono- or di(C1-6 alkyl)amino or C1-6 alkylcarbonylamino;
R3 is hydrogen or C1-6 alkyl;
L is C3-6 cycloalkyl, C5-6 cycloalkanone, C3-6 alkenyl optionally substituted with aryl, or L is a radical of the formula;
space="preserve" listing-type="equation">--Alk--X--R.sup.5 (b-
2),
space="preserve" listing-type="equation">--Alk--Y--C(═
O)--R.sup.7 (b-
3), or
space="preserve" listing-type="equation">--Alk--Y--C(═
O)--NR.sup.9 R.sup.10 (b-
4), wherein each Alk is C1-6 alkanediyl;
R5 is hydrogen, C1-6 alkyl, hydroxyC1-6 alkyl, C3-6 cycloalkyl, aryl or Het;
X is O, S, SO2 or NR6 said R6 being hydrogen, C1-6 alkyl or aryl;
R7 is hydrogen, C1-6 alkyl, C3-6 cycloalkyl, aryl, arylC1-6 alkyl, di(aryl)methyl, C1-6 alkyloxy or hydroxy;
Y is NR8 or a direct bond, said R8 being hydrogen, C1-6 alkyl or aryl;
R9 and R10 each independently are hydrogen, C1-6 alkyl, C3-6 cycloalkyl, aryl or arylC1-6 alkyl, orR9 and R10 combined with the nitrogen atom bearing R9 and R10 may form a pyrrolidinyl or piperidinyl ring both being optionally substituted with C1-6 alkyl, amino or mono- or di(C1-6 alkyl)amino, orR9 and R10 combined with the nitrogen atom bearing R9 and R10 may form a piperazinyl or 4-morpholinyl radical both being optionally substituted with C1-6 alkyl;
wherein in the foregoing;
aryl represents unsubstituted phenyl or phenyl substituted with 1, 2 or 3 substituents each independently selected from halo, hydroxy, C1-6 alkyl, C1-6 alkyloxy, aminosulfonyl, C1-6 alkylcarbonyl, nitro, trifluoromethyl, amino or aminocarbonyl; and
(I) Het represents a group of the formula;
##STR127## wherein;
m is 1 or 2;
each X1 and X2 independently represents O or S;
each R11 represents hydrogen, C1-4 alkyl, C1-4 alkyloxyC1-4 alkyl or hydroxyC1-4 alkyl; and
R12 represents hydrogen, halo or C1-4 alkyl, or(II) Het represents a cyclic ether selected from the group consisting of 1,3-dioxolanyl optionally substituted with C1-4 alkyl;
1,3-dioxanyl optionally substituted with C1-4 alkyl;
tetrahydrofuranyl optionally substituted with C1-4 alkyl;
tetrahydropyranyl optionally substituted with C1-4 alkyl;
2,3-dihydro-1,4-benzodioxinyl;
2,3-dihydrobenzofuran and 3,4-dihydro-1(2H)-benzopyranyl;
or(III) Het represents a member selected from the group consisting of pyrrolidinyl;
piperidinyl;
pyridinyl which is optionally substituted with one or two substituents each independently selected from halo, hydroxy, cyano, C1-6 alkyl, trifluoromethyl, C1-6 alkyloxy, aminocarbonyl, mono and di(C1-6 alkyl)aminocarbonyl, amino, mono and di(C1-6 alkyl)amino and C1-6 alkyl-oxycarbonyl;
pyrimidinyl which is optionally substituted with one or two substituents each independently selected from halo, hydroxy, cyano, C1-6 alkyl, C1-6 alkyloxy, amino and mono and di(C1-6 alkyl)amino;
pyridazinyl which is optionally substituted with C1-6 alkyl or halo;
pyrazinyl which is optionally substituted with one ore two substituents each independently selected from halo, hydroxy, cyano, C1-6 alkyl, C1-6 alkyloxy, amino, mono- and di(C1-6 alkyl)amino and C1-6 alkyloxy-carbonyl;
pyrrolyl which is optionally substituted with C1-6 alkyl;
pyrazolyl which is optionally substituted with C1-6 alkyl;
imidazolyl which is optionally substituted with C1-6 alkyl;
triazolyl which is optionally substituted with C1-6 alkyl;
quinolinyl optionally substituted with up to two substituents each independently selected from halo, hydroxy, cyano, C1-6 alkyl, C1-6 alkyloxy, amino, mono and di(C1-6 alkyl)amino and trifluoromethyl;
isoquinolinyl optionally substituted with up to two substituents each independently selected from halo, hydroxy, cyano, C1-6 alkyl, C1-6 alkyloxy, amino, mono and di(C1-6 alkyl)amino and trifluoromethyl;
quinoxalinyl optionally substituted with up to two substituents each independently selected from C1-6 alkyl, hydroxy, halo, cyano and C1-6 alkyloxy;
quinazolinyl optionally substituted with C1-6 alkyl;
benzimidazolyl optionally substituted with C1-6 alkyl;
indolyl optionally substituted with C1-6 alkyl;
5,6,7,8-tetrahydroquinolinyl optionally substituted with up to two substituents each independently selected from halo, hydroxy, cyano, C1-6 alkyl, C1-6 alkyloxy, amino, mono- and di(C1-6 alkyl)amino and trifluoromethyl;
5,6,7,8-tetrahydro-quinoxalinyl optionally substituted with up to two substituents each independently selected from C1-6 alkyl;
hydroxy, halo, cyano and C1-6 alkyloxy;
thiazolyl optionally substituted with C1-6 alkyl;
oxazolyl optionally substituted with C1-6 alkyl;
benzoxazolyl optionally substituted with C1-6 alkyl; and
benzothiazolyl optionally substituted with C1-6 alkyl;
(IV) Het represents a group of the formula;
##STR128## X3 is O or S;
R13 is hydrogen, C1-6 alkyl or arylC1-6 alkyl;
R14 is hydrogen, halo, C1-6 alkyl or aryl;
G1 is --CH2 --CH2 --, --CH═
CH--, --N═
N--, --C(═
O)--CH2 -- or --CH2 --CH2 --CH2 --, wherein one or two hydrogen atoms each independently may be replaced by C1-6 alkyl; and
G2 is --CH2 --CH2 --, --CH2 --N(R13)-- or --CH2 --CH2 --CH2 --, wherein one or two hydrogen atoms each independently may be replaced by C1-6 alkyl;
or(V) Het represents a group of the formula;
##STR129## wherein X4 and X5 each independently are O or S;
each R15 independently is hydrogen, C1-6 alkyl or arylC1-6 -alkyl;
each R16 independently is hydrogen, halo, C1-6 alkyl or C1-6 alkyloxy;
R17 is hydrogen, halo, C1-6 alkyl or aryl; and
each R18 independently is hydrogen, C1-6 alkyloxy or C1-6 alkyl,G3 is --CH═
CH--CH═
CH--, --(CH2)4 --, --S--(CH2)2 --, --S--(CH2)3 --, --S--CH═
CH--, --CH═
CH--O--, --NH--(CH2)2 --, --NH--(CH2)3 --, --NH--CH═
CH--, --NH--N═
CH--CH2 --, --NH--CH═
N-- or --NH--N═
CH--; and
G4 is --CH═
CH--CH═
CH--, --CH═
CCl--CH═
CH--, --CCl═
CH--CH═
CH--, --N═
CH--CH═
CH--, --CH═
N--CH═
CH--, --CH═
CH--N═
CH--, --CH═
CH--CH═
N--, --N═
CH--N═
CH-- or --CH═
N--CH═
N--,wherein the radicals (d-5), (d-6), (d-7) and (d-8) may be connected to Alk by replacing either a hydrogen or a radical R15 or R16 by a free bond.
0 Assignments
0 Petitions
Accused Products
Abstract
Piperidine derivatives of formula ##STR1## wherein A is a radical of formula
--CH.sub.2 --CH.sub.2 -- (a-1),
--CH.sub.2 --CH.sub.2 --CH.sub.2 -- (a-2), or
--CH.sub.2 --CH.sub.2 --CH.sub.2 --CH.sub.2 -- (a-3),
wherein one or two hydrogen atoms in said radicals (a-1) to (a-3) may be replaced by a C1-6 alkyl radical;
R1 is hydrogen or halo; R2 is hydrogen, amino, mono or di(C1-6 alkyl)amino or C1-6 alkylcarbonylamino; R3 is hydrogen or C1-6 alkyl; L is C3-6 cycloalkyl, C5-6 cycloalkanone, C3-6 alkenyl optionally substituted with aryl, or L is a radical of formula
--Alk--R.sup.4 (b-1),
--Alk--X--R.sup.5 (b-2),
--Alk--Y--C(═O)--R.sup.7 (b-3), or
--Alk--Y--C(═O)--NR.sup.9 R.sup.10 (b-4),
the N-oxide forms, addition salts and stereochemically isomeric forms thereof, said compounds having gastrointestinal motility stimulating properties. Pharmaceutical compositions containing these compounds as active ingredient, and a method of preparing said compounds and pharmaceutical compositions.
-
Citations
13 Claims
-
1. A compound of the formula:
- ##STR126## an N-oxide form, a salt or a sterochemically isomeric form thereof, wherein;
A is a radical of the formula;
space="preserve" listing-type="equation">--CH.sub.2 --CH.sub.2 -- (a-1),
space="preserve" listing-type="equation">--CH.sub.2 --CH.sub.2 --CH.sub.2 -- (a-2), or
space="preserve" listing-type="equation">--CH.sub.2 --CH.sub.2 --CH.sub.2 --CH.sub.2 -- (a-3),wherein one or two hydrogem atoms in said radicals (a-1) to (a-3) may be replaced by a C1-6 alkyl radical; R1 is hydrogen or halo; R2 is hydrogen, amino, mono- or di(C1-6 alkyl)amino or C1-6 alkylcarbonylamino; R3 is hydrogen or C1-6 alkyl; L is C3-6 cycloalkyl, C5-6 cycloalkanone, C3-6 alkenyl optionally substituted with aryl, or L is a radical of the formula;
space="preserve" listing-type="equation">--Alk--X--R.sup.5 (b-
2),
space="preserve" listing-type="equation">--Alk--Y--C(═
O)--R.sup.7 (b-
3), or
space="preserve" listing-type="equation">--Alk--Y--C(═
O)--NR.sup.9 R.sup.10 (b-
4),wherein each Alk is C1-6 alkanediyl; R5 is hydrogen, C1-6 alkyl, hydroxyC1-6 alkyl, C3-6 cycloalkyl, aryl or Het; X is O, S, SO2 or NR6 said R6 being hydrogen, C1-6 alkyl or aryl; R7 is hydrogen, C1-6 alkyl, C3-6 cycloalkyl, aryl, arylC1-6 alkyl, di(aryl)methyl, C1-6 alkyloxy or hydroxy; Y is NR8 or a direct bond, said R8 being hydrogen, C1-6 alkyl or aryl; R9 and R10 each independently are hydrogen, C1-6 alkyl, C3-6 cycloalkyl, aryl or arylC1-6 alkyl, or R9 and R10 combined with the nitrogen atom bearing R9 and R10 may form a pyrrolidinyl or piperidinyl ring both being optionally substituted with C1-6 alkyl, amino or mono- or di(C1-6 alkyl)amino, or R9 and R10 combined with the nitrogen atom bearing R9 and R10 may form a piperazinyl or 4-morpholinyl radical both being optionally substituted with C1-6 alkyl; wherein in the foregoing; aryl represents unsubstituted phenyl or phenyl substituted with 1, 2 or 3 substituents each independently selected from halo, hydroxy, C1-6 alkyl, C1-6 alkyloxy, aminosulfonyl, C1-6 alkylcarbonyl, nitro, trifluoromethyl, amino or aminocarbonyl; and (I) Het represents a group of the formula;
##STR127## wherein;
m is 1 or 2;each X1 and X2 independently represents O or S; each R11 represents hydrogen, C1-4 alkyl, C1-4 alkyloxyC1-4 alkyl or hydroxyC1-4 alkyl; and R12 represents hydrogen, halo or C1-4 alkyl, or (II) Het represents a cyclic ether selected from the group consisting of 1,3-dioxolanyl optionally substituted with C1-4 alkyl;
1,3-dioxanyl optionally substituted with C1-4 alkyl;
tetrahydrofuranyl optionally substituted with C1-4 alkyl;
tetrahydropyranyl optionally substituted with C1-4 alkyl;
2,3-dihydro-1,4-benzodioxinyl;
2,3-dihydrobenzofuran and 3,4-dihydro-1(2H)-benzopyranyl;
or(III) Het represents a member selected from the group consisting of pyrrolidinyl;
piperidinyl;
pyridinyl which is optionally substituted with one or two substituents each independently selected from halo, hydroxy, cyano, C1-6 alkyl, trifluoromethyl, C1-6 alkyloxy, aminocarbonyl, mono and di(C1-6 alkyl)aminocarbonyl, amino, mono and di(C1-6 alkyl)amino and C1-6 alkyl-oxycarbonyl;
pyrimidinyl which is optionally substituted with one or two substituents each independently selected from halo, hydroxy, cyano, C1-6 alkyl, C1-6 alkyloxy, amino and mono and di(C1-6 alkyl)amino;
pyridazinyl which is optionally substituted with C1-6 alkyl or halo;
pyrazinyl which is optionally substituted with one ore two substituents each independently selected from halo, hydroxy, cyano, C1-6 alkyl, C1-6 alkyloxy, amino, mono- and di(C1-6 alkyl)amino and C1-6 alkyloxy-carbonyl;
pyrrolyl which is optionally substituted with C1-6 alkyl;
pyrazolyl which is optionally substituted with C1-6 alkyl;
imidazolyl which is optionally substituted with C1-6 alkyl;
triazolyl which is optionally substituted with C1-6 alkyl;
quinolinyl optionally substituted with up to two substituents each independently selected from halo, hydroxy, cyano, C1-6 alkyl, C1-6 alkyloxy, amino, mono and di(C1-6 alkyl)amino and trifluoromethyl;
isoquinolinyl optionally substituted with up to two substituents each independently selected from halo, hydroxy, cyano, C1-6 alkyl, C1-6 alkyloxy, amino, mono and di(C1-6 alkyl)amino and trifluoromethyl;
quinoxalinyl optionally substituted with up to two substituents each independently selected from C1-6 alkyl, hydroxy, halo, cyano and C1-6 alkyloxy;
quinazolinyl optionally substituted with C1-6 alkyl;
benzimidazolyl optionally substituted with C1-6 alkyl;
indolyl optionally substituted with C1-6 alkyl;
5,6,7,8-tetrahydroquinolinyl optionally substituted with up to two substituents each independently selected from halo, hydroxy, cyano, C1-6 alkyl, C1-6 alkyloxy, amino, mono- and di(C1-6 alkyl)amino and trifluoromethyl;
5,6,7,8-tetrahydro-quinoxalinyl optionally substituted with up to two substituents each independently selected from C1-6 alkyl;
hydroxy, halo, cyano and C1-6 alkyloxy;
thiazolyl optionally substituted with C1-6 alkyl;
oxazolyl optionally substituted with C1-6 alkyl;
benzoxazolyl optionally substituted with C1-6 alkyl; and
benzothiazolyl optionally substituted with C1-6 alkyl;(IV) Het represents a group of the formula;
##STR128## X3 is O or S;
R13 is hydrogen, C1-6 alkyl or arylC1-6 alkyl;R14 is hydrogen, halo, C1-6 alkyl or aryl; G1 is --CH2 --CH2 --, --CH═
CH--, --N═
N--, --C(═
O)--CH2 -- or --CH2 --CH2 --CH2 --, wherein one or two hydrogen atoms each independently may be replaced by C1-6 alkyl; andG2 is --CH2 --CH2 --, --CH2 --N(R13)-- or --CH2 --CH2 --CH2 --, wherein one or two hydrogen atoms each independently may be replaced by C1-6 alkyl;
or(V) Het represents a group of the formula;
##STR129## wherein X4 and X5 each independently are O or S;
each R15 independently is hydrogen, C1-6 alkyl or arylC1-6 -alkyl;each R16 independently is hydrogen, halo, C1-6 alkyl or C1-6 alkyloxy; R17 is hydrogen, halo, C1-6 alkyl or aryl; and each R18 independently is hydrogen, C1-6 alkyloxy or C1-6 alkyl, G3 is --CH═
CH--CH═
CH--, --(CH2)4 --, --S--(CH2)2 --, --S--(CH2)3 --, --S--CH═
CH--, --CH═
CH--O--, --NH--(CH2)2 --, --NH--(CH2)3 --, --NH--CH═
CH--, --NH--N═
CH--CH2 --, --NH--CH═
N-- or --NH--N═
CH--; andG4 is --CH═
CH--CH═
CH--, --CH═
CCl--CH═
CH--, --CCl═
CH--CH═
CH--, --N═
CH--CH═
CH--, --CH═
N--CH═
CH--, --CH═
CH--N═
CH--, --CH═
CH--CH═
N--, --N═
CH--N═
CH-- or --CH═
N--CH═
N--,wherein the radicals (d-5), (d-6), (d-7) and (d-8) may be connected to Alk by replacing either a hydrogen or a radical R15 or R16 by a free bond. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)
- ##STR126## an N-oxide form, a salt or a sterochemically isomeric form thereof, wherein;
-
13. A compound having the formula:
- ##STR130## a N-oxide form, a salt or a stereochemically isomeric form thereof, wherein
A is a radical of formula
space="preserve" listing-type="equation">--CH.sub.2 --CH.sub.2 -- (a-1),
space="preserve" listing-type="equation">--CH.sub.2 --CH.sub.2 --CH.sub.2 -- (a-2), or
space="preserve" listing-type="equation">--CH.sub.2 --CH.sub.2 --CH.sub.2 --CH.sub.2 -- (a-3),wherein one or two hydrogen atoms in said radicals (a-1) to (a-3) may be replaced by a C1-6 alkyl radical; R1 is hydrogen or halo; R2 is hydrogen, amino, mono or di(C1-6 alkyl)amino or C1-6 alkylcarbonylamino; and R3 is hydrogen or C1-6 alkyl.
- ##STR130## a N-oxide form, a salt or a stereochemically isomeric form thereof, wherein
Specification